Wang Heyue, Qin Yaxin, Niu Jinzhu, Chen Haowen, Lu Xinda, Wang Rui, Han Jianli
Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Ann Med. 2025 Dec;57(1):2472856. doi: 10.1080/07853890.2025.2472856. Epub 2025 Mar 12.
This review examines the evolution of obesity evaluation methods, from traditional anthropometric indices to advanced imaging techniques, focusing on their clinical utility, limitations, and potential for personalized assessment of visceral adiposity and associated metabolic risks. A comprehensive analysis of existing literature was conducted, encompassing anthropometric indices (BMI, WC, WHR, WHtR, NC), lipid-related metrics (LAP, VAI, CVAI, mBMI), and imaging technologies (3D scanning, BIA, ultrasound, DXA, CT, MRI). The study highlights the biological roles of white, brown, and beige adipocytes, emphasizing visceral adipose tissue (VAT) as a critical mediator of metabolic diseases. Although BMI and other anthropometric measurements are still included in the guidelines, indicators that incorporate lipid metabolism information can more accurately reflect the relationship between metabolic diseases and visceral obesity. At the same time, the use of more modern medical equipment, such as ultrasound, X-rays, and CT scans, allows for a more intuitive assessment of the extent of visceral obesity.
本综述探讨了肥胖评估方法的演变,从传统人体测量指标到先进成像技术,重点关注其临床实用性、局限性以及对内脏脂肪和相关代谢风险进行个性化评估的潜力。对现有文献进行了全面分析,涵盖人体测量指标(BMI、腰围、腰臀比、腰高比、颈围)、脂质相关指标(脂质蓄积产物、内脏脂肪指数、心血管风险评估指数、代谢性BMI)和成像技术(三维扫描、生物电阻抗分析、超声、双能X线吸收法、CT、MRI)。该研究强调了白色、棕色和米色脂肪细胞的生物学作用,强调内脏脂肪组织是代谢性疾病的关键介质。尽管BMI和其他人体测量指标仍被纳入指南,但纳入脂质代谢信息的指标能更准确地反映代谢性疾病与内脏肥胖之间的关系。同时,使用更现代的医疗设备,如超声、X射线和CT扫描,能够更直观地评估内脏肥胖的程度。